Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Protein and Peptide Letters
|
April 5, 2023
Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct
Niloofar Khairkhah, Fatemeh Shahhosseini, Elnaz Agi, et al.
Journal of Pharmaceutical Sciences
|
October 9, 2025
Investigation of synergistic effects of β-defensin, vesatolimod and resiquimod in increasing the potency of a therapeutic HIV-1 vaccine candidate
Seyedeh Somayeh Hosseini Alarzi, Azam Bolhassani, Elnaz Agi, et al.
Plos One
|
June 9, 2022
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
Niloofar Khairkhah, Azam Bolhassani, Elnaz Agi, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
January 24, 2025
Investigation of the Potency of KALA and REV Cell-Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct
Haleh Feyzyab, Alireza Milani, Elnaz Agi, et al.
Immunotherapy
|
April 23, 2020
Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses
Heidar Ali Panahi, Azam Bolhassani, Gholamreza Javadi, et al.
IUBMB Life
|
April 21, 2016
Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response
Golnaz Mardani, Azam Bolhassani, Elnaz Agi, et al.
Protein and Peptide Letters
|
January 4, 2021
HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?
Alireza Milani, Kazem Baesi, Elnaz Agi, et al.
Molecular Immunology
|
February 26, 2019
Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?
Azam Bolhassani, Sepideh Shahbazi, Elnaz Agi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 9, 2016
Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines
Somayeh Talebi, Azam Bolhassani, Seyed Mehdi Sadat, et al.
Microbes and Infection
|
February 16, 2025
Immunostimulatory effects of Hsp70 fragments-modified DCs: A computational and experimental study in HIV vaccine design
Elahe Akbari, Alireza Milani, Parisa Moradi Pordanjani, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Protein and Peptide Letters
|
April 5, 2023
Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct
Niloofar Khairkhah, Fatemeh Shahhosseini, Elnaz Agi, et al.
Journal of Pharmaceutical Sciences
|
October 9, 2025
Investigation of synergistic effects of β-defensin, vesatolimod and resiquimod in increasing the potency of a therapeutic HIV-1 vaccine candidate
Seyedeh Somayeh Hosseini Alarzi, Azam Bolhassani, Elnaz Agi, et al.
Plos One
|
June 9, 2022
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
Niloofar Khairkhah, Azam Bolhassani, Elnaz Agi, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
January 24, 2025
Investigation of the Potency of KALA and REV Cell-Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct
Haleh Feyzyab, Alireza Milani, Elnaz Agi, et al.
Immunotherapy
|
April 23, 2020
Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses
Heidar Ali Panahi, Azam Bolhassani, Gholamreza Javadi, et al.
IUBMB Life
|
April 21, 2016
Protein vaccination with HPV16 E7/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response
Golnaz Mardani, Azam Bolhassani, Elnaz Agi, et al.
Protein and Peptide Letters
|
January 4, 2021
HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?
Alireza Milani, Kazem Baesi, Elnaz Agi, et al.
Molecular Immunology
|
February 26, 2019
Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?
Azam Bolhassani, Sepideh Shahbazi, Elnaz Agi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 9, 2016
Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines
Somayeh Talebi, Azam Bolhassani, Seyed Mehdi Sadat, et al.
Microbes and Infection
|
February 16, 2025
Immunostimulatory effects of Hsp70 fragments-modified DCs: A computational and experimental study in HIV vaccine design
Elahe Akbari, Alireza Milani, Parisa Moradi Pordanjani, et al.
Page
of 3